This summary highlights major health news, including EU's endorsement of Novo Nordisk's Wegovy for heart conditions in ...

“Albert Einstein, Mystery Solved” featuring the art of late artist James Yale, whose art hasn’t been shown for 16 years, is ...

Markers in the blood can predict how multiple sclerosis will develop and what drugs will be ­effective, a study found.

Recent developments in health include EU approval of Novo's Wegovy for obesity-related heart conditions, the US FDA's nod for ...

Women had a lower probability of receiving any disease-modifying treatment (DMT) and were even less likely to get ...

What's new at Jacksonville Public Library: "Colored Television" by Danzy Senna: Jane has high hopes that her life is about to ...

Bucks County resident Joseph “Smiley” Terinoni was recently presented with a citation from the Pennsylvania House of ...

Jeeping for Multiple Sclerosis brings awareness and resources to the Heights ...

Danity Kane singer Dawn Richard accuses Diddy of groping her and threatening her life. She also claims to have witnessed him ...

Among 282 patients with pediatric-onset MS, 39% started high-efficacy therapy early (at ages 12-17), and 61% started late ...

The Bruton's tyrosine kinase inhibitor tolebrutinib is reportedly the first agent to show benefit in patients with nonrelapsing secondary progressive MS.

ECTRIMS 2024 Investor Science Call September 20, 2024 10:00 AM ETCompany ParticipantsThomas Kudsk - IRJiwon Oh - MD, PhD, St.